Immunohistochemical Pharmacokinetics of the Anti-diabetes Drug Alogliptin in Rat Kidney and Liver

Alogliptin is one of a new class of therapeutic agents for type 2 diabetes called dipeptidyl peptidase-4 inhibitors. Here, we used immunohistochemistry to investigate the pharmacokinetics of alogliptin at the cell and tissue levels in the rat kidney and liver. One hour after alogliptin administratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yutaro, Yamamoto, Yuta, Saita, Tetsuya, Hira, Daisuke, Chijiwa, Takahito, Shin, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2020
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322161/
https://www.ncbi.nlm.nih.gov/pubmed/32624630
http://dx.doi.org/10.1267/ahc.19036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322161/
https://www.ncbi.nlm.nih.gov/pubmed/32624630
http://dx.doi.org/10.1267/ahc.19036

Ejemplares similares